BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6263716)

  • 1. Drugs inhibiting the renin - angiotensin system.
    Antonaccio MJ; Cushman DW
    Fed Proc; 1981 Jun; 40(8):2275-84. PubMed ID: 6263716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of the renin-angiotensin system as new antihypertensive agents.
    Antonaccio MJ
    Clin Exp Hypertens A; 1982; 4(1-2):27-46. PubMed ID: 6176373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides as targets for antihypertensive drug development.
    Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
    J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The renin-angiotensin system and its inhibition (author's transl)].
    Corvol P; Elkik F; Thibonnier M; Plouin PF; Menard J
    Nouv Presse Med; 1981 Apr; 10(19):1525-30. PubMed ID: 6269554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitors: specific modulators of the renin-angiotensin system.
    Luther RR; Stein HH; Glassman HN; Kleinert HD
    Arzneimittelforschung; 1989 Jan; 39(1):1-5. PubMed ID: 2655608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does?
    Haber E
    J Hypertens; 1984 Jun; 2(3):223-30. PubMed ID: 6099385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
    Kuska J; Germakowska-Kowalik T; Pluta S
    Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitors of the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interferences with the renin-angiotensin system.
    Ganten D; Unger T; Lang RE
    Arzneimittelforschung; 1984; 34(10B):1391-8. PubMed ID: 6097263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system and body function.
    Reid IA
    Arch Intern Med; 1985 Aug; 145(8):1475-9. PubMed ID: 2992406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide inhibitors of renin in cardiovascular studies.
    Haber E
    Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corpuscles of Stannius secrete renin or an isorenin that regulates cardiovascular function in freshwater North American eels, Anguilla rostrata LeSueur.
    Butler DG; Zhang DH
    Gen Comp Endocrinol; 2001 Nov; 124(2):199-217. PubMed ID: 11703085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.